# CF Bankshares Inc.: financial statements, quarterly

CFBK · Nasdaq · CIK 1070680 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/cfbk.md) · [Financials](/companies/cfbk/financials.md) · [Filings](/companies/cfbk/filings.md) · [Insiders](/companies/cfbk/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/cfbk/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Interest expense | $m | [16.5](/filings/0001070680-23-000039.md) | [18.0 d](/filings/0001070680-24-000006.md) | [17.8](/filings/0001070680-24-000017.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [1.0](/filings/0001070680-24-000033.md) | [0.9 d](/filings/0001193125-26-103638.md) | [0.7](/filings/0000950170-25-068706.md) | [0.2](/filings/0000950170-25-105500.md) | [1.1](/filings/0001193125-25-271208.md) | [0.7 d](/filings/0001193125-26-103638.md) | [1.1](/filings/0001193125-26-215923.md) | [1.4](/filings/0001193125-26-339475.md) | [0.4](/filings/0001193125-25-271208.md) | [1.1 d](/filings/0001193125-26-103638.md) | [0.9](/filings/0001193125-26-215923.md) | [1.4](/filings/0001193125-26-339475.md) |
| Net income | $m | [4.0](/filings/0001070680-24-000033.md) | [4.2 d](/filings/0001193125-26-103638.md) | [3.1](/filings/0000950170-25-068706.md) | [1.7](/filings/0000950170-25-105500.md) | [4.2](/filings/0001193125-25-271208.md) | [4.4 d](/filings/0001193125-26-103638.md) | [4.4](/filings/0001193125-26-215923.md) | [5.0](/filings/0001193125-26-339475.md) | [2.3](/filings/0001193125-25-271208.md) | [5.7 d](/filings/0001193125-26-103638.md) | [5.0](/filings/0001193125-26-215923.md) | [5.9](/filings/0001193125-26-339475.md) |
| Diluted EPS | $ per share | [0.62](/filings/0001070680-24-000033.md) | not reported | [0.47](/filings/0000950170-25-068706.md) | [0.26](/filings/0000950170-25-105500.md) | [0.65](/filings/0001193125-25-271208.md) | not reported | [0.68](/filings/0001193125-26-215923.md) | [0.77](/filings/0001193125-26-339475.md) | [0.36](/filings/0001193125-25-271208.md) | not reported | [0.77](/filings/0001193125-26-215923.md) | [0.90](/filings/0001193125-26-339475.md) |
| Basic EPS | $ per share | [0.63](/filings/0001070680-24-000033.md) | not reported | [0.48](/filings/0000950170-25-068706.md) | [0.26](/filings/0000950170-25-105500.md) | [0.65](/filings/0001193125-25-271208.md) | not reported | [0.68](/filings/0001193125-26-215923.md) | [0.77](/filings/0001193125-26-339475.md) | [0.36](/filings/0001193125-25-271208.md) | not reported | [0.77](/filings/0001193125-26-215923.md) | [0.91](/filings/0001193125-26-339475.md) |

- Revenue: not reported
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [230](/filings/0001070680-23-000039.md) | [262](/filings/0001070680-25-000010.md) | [237](/filings/0001070680-24-000017.md) | [242](/filings/0001070680-24-000027.md) | [234](/filings/0001070680-24-000033.md) | [235](/filings/0001193125-26-103638.md) | [241](/filings/0000950170-25-068706.md) | [276](/filings/0000950170-25-105500.md) | [272](/filings/0001193125-25-271208.md) | [259](/filings/0001193125-26-339475.md) | [268](/filings/0001193125-26-215923.md) | [253](/filings/0001193125-26-339475.md) |
| Total assets | $m | [1,992](/filings/0001070680-23-000039.md) | [2,059](/filings/0001070680-25-000010.md) | [2,039](/filings/0001070680-24-000017.md) | [2,041](/filings/0001070680-24-000027.md) | [2,066](/filings/0001070680-24-000033.md) | [2,066](/filings/0001193125-26-103638.md) | [2,095](/filings/0000950170-25-068706.md) | [2,134](/filings/0000950170-25-105500.md) | [2,111](/filings/0001193125-25-271208.md) | [2,117](/filings/0001193125-26-339475.md) | [2,146](/filings/0001193125-26-215923.md) | [2,170](/filings/0001193125-26-339475.md) |
| Total liabilities | $m | [1,841](/filings/0001070680-23-000039.md) | [1,903](/filings/0001070680-25-000010.md) | [1,881](/filings/0001070680-24-000017.md) | [1,881](/filings/0001070680-24-000027.md) | [1,902](/filings/0001070680-24-000033.md) | [1,897](/filings/0001193125-26-103638.md) | [1,922](/filings/0000950170-25-068706.md) | [1,957](/filings/0000950170-25-105500.md) | [1,932](/filings/0001193125-25-271208.md) | [1,933](/filings/0001193125-26-339475.md) | [1,957](/filings/0001193125-26-215923.md) | [1,975](/filings/0001193125-26-339475.md) |
| Long-term debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [151](/filings/0001070680-24-000033.md) | [155](/filings/0001193125-26-103638.md) | [158](/filings/0000950170-25-105500.md) | [160](/filings/0001193125-25-271208.md) | [164](/filings/0001193125-25-271208.md) | [168](/filings/0001193125-26-339475.md) | [173](/filings/0001193125-26-339475.md) | [177](/filings/0001193125-26-339475.md) | [179](/filings/0001193125-25-271208.md) | [184](/filings/0001193125-26-339475.md) | [189](/filings/0001193125-26-339475.md) | [194](/filings/0001193125-26-339475.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [2.5 d](/filings/0001070680-24-000033.md) | [8.0 d](/filings/0001193125-26-103638.md) | [(1.2)](/filings/0000950170-25-068706.md) | [4.0 d](/filings/0000950170-25-105500.md) | [(1.3) d](/filings/0001193125-25-271208.md) | [12.6 d](/filings/0001193125-26-103638.md) | [2.2](/filings/0001193125-26-215923.md) | [8.0 d](/filings/0001193125-26-339475.md) | [5.5 d](/filings/0001193125-25-271208.md) | [3.0 d](/filings/0001193125-26-103638.md) | [4.7](/filings/0001193125-26-215923.md) | [5.1 d](/filings/0001193125-26-339475.md) |
| Capital expenditure | $m | [0.0 d](/filings/0001070680-24-000033.md) | [0.0 d](/filings/0001193125-26-103638.md) | [0.0](/filings/0000950170-25-068706.md) | [0.0 d](/filings/0000950170-25-105500.md) | [0.0 d](/filings/0001193125-25-271208.md) | [0.2 d](/filings/0001193125-26-103638.md) | [0.1](/filings/0001193125-26-215923.md) | [0.1 d](/filings/0001193125-26-339475.md) | [0.3 d](/filings/0001193125-25-271208.md) | [0.1 d](/filings/0001193125-26-103638.md) | [0.1](/filings/0001193125-26-215923.md) | [0.0 d](/filings/0001193125-26-339475.md) |
| Dividends paid | $m | [0.4 d](/filings/0001070680-24-000033.md) | [0.4 d](/filings/0001193125-26-103638.md) | [0.4](/filings/0000950170-25-068706.md) | [0.4 d](/filings/0000950170-25-105500.md) | [0.4 d](/filings/0001193125-25-271208.md) | [0.5 d](/filings/0001193125-26-103638.md) | [0.5](/filings/0001193125-26-215923.md) | [0.5 d](/filings/0001193125-26-339475.md) | [0.5 d](/filings/0001193125-25-271208.md) | [0.5 d](/filings/0001193125-26-103638.md) | [0.6](/filings/0001193125-26-215923.md) | [0.6 d](/filings/0001193125-26-339475.md) |
| Share repurchases | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: not reported

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | thousands of shares | [6,548](/filings/0001070680-23-000039.md) | [6,543](/filings/0001070680-24-000017.md) | [6,434](/filings/0001070680-24-000027.md) | [6,457](/filings/0001070680-24-000033.md) | [6,357](/filings/0000950170-25-068706.md) | [6,256](/filings/0000950170-25-105500.md) | [6,294](/filings/0001193125-25-271208.md) | [6,286](/filings/0001193125-26-215923.md) | [6,345](/filings/0001193125-26-339475.md) | [6,346](/filings/0001193125-25-271208.md) | [6,308](/filings/0001193125-26-215923.md) | [6,364](/filings/0001193125-26-339475.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 5,316,573 at 2020-05-01, from the cover of the [10-Q filed 2020-05-13](/filings/0001070680-20-000017.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:32 ET. No prices; not investment advice.